drugset / Trial / NCT00047840

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

NCT00047840

Phase 2 Completed 129 enrolled Genzyme, a Sanofi Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

Timeline

Start
2002-10
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vandetanib Small molecule
Background Docetaxel Small molecule